title: Nonfamilial, MPL S505N-Mutated Essential Thrombocythaemia.
abstract: Mutations of MPL are present in a significant proportion of patients with the myeloproliferative neoplasms (MPN), primary myelofibrosis (PMF), and essential thrombocythaemia (ET). The most frequent of these mutations, W515L and W515K, occur in exon 10 of MPL, which encodes the receptor for thrombopoietin. Another exon 10 mutation, MPL S505N, has been shown to be a founder mutation in several pedigrees with familial thrombocythaemia where it is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis. Rare cases of sporadic, nonfamilial, MPL S505N MPN have been documented, but the presenting laboratory and clinical features have not been described in detail. The diagnosis and clinical course of a case of MPL S505N-positive MPN are presented with diagnostic features and treatment response resembling typical ET but with evidence of increasing bone marrow fibrosis. Further MPN cases possessing this genotype require reporting in order to ascertain whether any particular morphological or clinical features, if present, determine clinical course and aid the refinement of therapeutic options.
authors: Department of Haematology, Midland Regional Hospital, Tullamore, Ireland.
authors: Ruth
authors: R
authors: Morrell
authors: Stephen E
authors: SE
authors: Langabeer
authors: Liam
authors: L
authors: Smyth
authors: Meegahage
authors: M
authors: Perera
authors: Gerard
authors: G
authors: Crotty
references: J Clin Oncol. 2009 Jun 20;27(18):2991-9
references: 19364963
references: Br J Haematol. 2010 Apr;149(2):250-7
references: 20151976
references: Haematologica. 2009 Jan;94(1):141-4
references: 19029146
references: Br J Haematol. 2013 Jan;160(1):25-34
references: 23057517
references: Blood. 2006 Nov 15;108(10):3472-6
references: 16868251
references: Haematologica. 2009 Oct;94(10):1368-74
references: 19608689
references: J Mol Diagn. 2008 Sep;10(5):435-41
references: 18669880
references: Leukemia. 2008 Aug;22(8):1557-66
references: 18528423
references: PLoS One. 2011;6(8):e23396
references: 21858098
references: Int J Hematol. 2009 Oct;90(3):431-432
references: 19728022
references: Blood Cells Mol Dis. 2011 Jun 15;47(1):67-71
references: 21555228
references: Acta Haematol. 2010;124(3):160-1
references: 20938171
references: Diagn Mol Pathol. 2011 Mar;20(1):34-9
references: 21326037
references: Leukemia. 2012 Apr;26(4):720-7
references: 22005786
references: Blood. 2004 Jun 1;103(11):4198-200
references: 14764528
references: Haematologica. 2010 Jan;95(1):65-70
references: 19713221
references: Haematologica. 2011 Apr;96(4):607-11
references: 21228032
references: Blood. 2010 Apr 8;115(14):2919-27
references: 20154217
references: Blood. 2008 Aug 1;112(3):844-7
references: 18519816
references: Blood. 2008 Jul 1;112(1):141-9
references: 18451306